115 related articles for article (PubMed ID: 9561057)
21. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
[TBL] [Abstract][Full Text] [Related]
22. Optimization of a negative oral contrast agent for magnetic resonance imaging.
Davis MA; Mei H; Ritsema GH
Invest Radiol; 1994 Jun; 29 Suppl 2():S120-2. PubMed ID: 7928205
[No Abstract] [Full Text] [Related]
23. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.
Klein C; Nagel E; Schnackenburg B; Bornstedt A; Schalla S; Hoffmann V; Lehning A; Fleck E
MAGMA; 2000 Nov; 11(1-2):65-7. PubMed ID: 11186991
[No Abstract] [Full Text] [Related]
24. Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient.
Hammerstingl R; Vogl TJ; Schwarz W; Kümmel S; Balzer T; Neuhaus P; Felix R
Acad Radiol; 1998 Apr; 5 Suppl 1():S75-9; discussion S93-4. PubMed ID: 9561049
[No Abstract] [Full Text] [Related]
25. Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan).
Bremerich J; Roberts TP; Wendland MF; Wyttenbach R; Arheden H; Reddy GP; Shafaghi N; Higgins CB; Saeed M
J Magn Reson Imaging; 2000 Jun; 11(6):622-8. PubMed ID: 10862061
[TBL] [Abstract][Full Text] [Related]
26. Vascular enhancement with superparamagnetic iron oxide.
Van Gansbeke D; Matos C; Metens T
AJR Am J Roentgenol; 1996 Sep; 167(3):813-4. PubMed ID: 8751704
[No Abstract] [Full Text] [Related]
27. Multislice breath-hold spiral magnetic resonance coronary angiography in patients with coronary artery disease: effect of intravascular contrast medium.
Knuesel PR; Nanz D; Wolfensberger U; Saranathan M; Lehning A; Luescher TF; Marincek B; von Schulthess GK; Schwitter J
J Magn Reson Imaging; 2002 Dec; 16(6):660-7. PubMed ID: 12451579
[TBL] [Abstract][Full Text] [Related]
28. Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma.
Guiu B; Loffroy R; Ben Salem D; Lepage C; Guiu S; Aho S; Jouve JL; Krausé D; Cercueil JP
Abdom Imaging; 2008; 33(5):520-8. PubMed ID: 17912584
[TBL] [Abstract][Full Text] [Related]
29. Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging.
Bunce NH; Keegan J; Gatehouse PD; Moon JC; Firmin DN; Hoffmann V; Pennell DJ
J Magn Reson Imaging; 2002 Aug; 16(2):217-23. PubMed ID: 12203771
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
31. New contrast agents for cardiovascular MRI and MRA.
Stillman AE
Int J Cardiovasc Imaging; 2001 Dec; 17(6):471-2. PubMed ID: 12365548
[No Abstract] [Full Text] [Related]
32. Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI.
Semelka RC; Lee JK; Worawattanakul S; Noone TC; Patt RH; Ascher SM
J Magn Reson Imaging; 1998; 8(3):670-4. PubMed ID: 9626884
[TBL] [Abstract][Full Text] [Related]
33. Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography.
Tanimoto A; Yuasa Y; Hiramatsu K
Acad Radiol; 1998 Apr; 5 Suppl 1():S113-5. PubMed ID: 9561058
[No Abstract] [Full Text] [Related]
34. Detection of myocardial capillary orientation with intravascular iron-oxide nanoparticles in spin-echo MRI.
Vignaud A; Rodriguez I; Ennis DB; DeSilva R; Kellman P; Taylor J; Bennett E; Wen H
Magn Reson Med; 2006 Apr; 55(4):725-30. PubMed ID: 16506158
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study.
Ahlström KH; Johansson LO; Rodenburg JB; Ragnarsson AS; Akeson P; Börseth A
Radiology; 1999 Jun; 211(3):865-9. PubMed ID: 10352617
[TBL] [Abstract][Full Text] [Related]
36. Breath-hold coronary MR angiography with volume-targeted imaging.
Wielopolski PA; van Geuns RJ; de Feyter PJ; Oudkerk M
Radiology; 1998 Oct; 209(1):209-19. PubMed ID: 9769834
[TBL] [Abstract][Full Text] [Related]
37. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
Simon GH; von Vopelius-Feldt J; Wendland MF; Fu Y; Piontek G; Schlegel J; Chen MH; Daldrup-Link HE
J Magn Reson Imaging; 2006 May; 23(5):720-7. PubMed ID: 16557494
[TBL] [Abstract][Full Text] [Related]
38. Projection imaging of the right coronary artery with an intravenous injection of contrast agent.
Green JD; Schirf BE; Omary RA; McCarthy RM; Carr JC; Li D
Magn Reson Med; 2004 Oct; 52(4):699-703. PubMed ID: 15389947
[TBL] [Abstract][Full Text] [Related]
39. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
Mikhaylova M; Stasinopoulos I; Kato Y; Artemov D; Bhujwalla ZM
Cancer Gene Ther; 2009 Mar; 16(3):217-26. PubMed ID: 18927599
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced MR angiography from the distal aorta to the ankle joint with a step-by-step technique.
Huber A; Heuck A; Baur A; Helmberger T; Waggershauser T; Billing A; Heiss M; Petsch R; Reiser M
AJR Am J Roentgenol; 2000 Nov; 175(5):1291-8. PubMed ID: 11044026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
